Further Information
FGFR1, H2, H3, H4, H5, CEK, FLG, FLT2, KAL2, BFGFR, C-FGR, N-SAM, fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome), FLG protein, N-sam tyrosine kinase, tyrosylprotein kinase, protein-tyrosine kinase, FMS-like tyrosine kinase 2, hydroxyaryl-protein kinase, fms-related tyrosine kinase-2, heparin-binding growth factor receptor, basic fibroblast growth factor receptor 1, fibroblast growth factor receptor 1, CD331, FGFBR, FLJ99988, HBGFR, OGD, OTTHUMP00000190881, soluble FGFR1 variant 1, soluble FGFR1 variant 2
Peptide ELISA: antibody detection limit dilution 1:32000.Western Blot:Approx 75kDa band observed in Human Breast lysates (calculated MW of 82.2kDa according to NP_075593, 81.9kDa according to NP_075594). Recommended concentration: 0.3-1ug/ml.Immunohistochemistry:In paraffin embedded Human Small Intestine shows staining of the enterocytic cytoplasm. Recommended concentration: 4-6ug/ml. Paraffin embedded Human Kidney. Recommended concentration: 4ug/ml.
- Torry DS, Mukherjea D, Arroyo J, Torry RJ. Expression and function of placenta growth factor: implications for abnormal placentation. J Soc Gynecol Investig. 2003 May;10(4):178-88. Review.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Dog, Cow
The immunogen for this antibody is: CLPRHPAQLANGGLKR
2260
fibroblast growth factor receptor 1
FGFR1
Homo sapiens
Liquid
NP_075598.2, NP_056934.2, NP_075593.1, NP_075594.1, NP_075599.1
11276087
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer
This antibody is expected to recognise five isoforms (as represented by NP_075598.2; NP_056934.2; NP_075593.1; NP_075594.1; NP_075599.1).
P11362